Sanofi-Aventis News
Most Popular Sanofi-Aventis Story
Genzyme revives Fabrazyme with EMA plant OK
Genzyme flexed some market muscle Wednesday when it announced the European Medicines Agency's approval of a new U.S. facility for production of Fabrazyme. Perhaps most immediately affected by the Read more...
Latest Headlines
- January 24, 2012
- January 18, 2012
- January 3, 2012
- December 20, 2011
- December 20, 2011
- November 4, 2011
- October 26, 2011
- October 24, 2011
- October 12, 2011
- October 10, 2011
- September 4, 2011
- June 19, 2011
- May 20, 2011
- May 17, 2011
- February 23, 2011
- February 18, 2011
- February 16, 2011
- December 6, 2010
- November 17, 2010
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
